C

Coastal Connecticut Research | New London, CT

Research site
(Unclaimed)
Location
342 Montauk Avenue, New London, Connecticut, United States of America
Site insights

Top conditions

Alzheimer Disease (4 trials)

Attention Deficit Disorder with Hyperactivity (3 trials)

Hyperkinesis (3 trials)

Stress Urinary Incontinence (3 trials)

Enuresis (3 trials)

Top treatments

Estradiol
Enobosarm
fezolinetant
GTx-024
Troriluzole
Vibegron
Guanfacine HCl
Dapagliflozin
Florbetapir
Leuco-methylthioninium Bis(Hydromethanesulfonate)

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 34
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Recently updated
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compul...

Enrolling
Obsessive-Compulsive Disorder
Drug: Placebo
Drug: Troriluzole

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Enrolling
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

Trial sponsors

G

GTx (3 trials)

Astellas logo

Astellas (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems